Registration Dossier

Administrative data

Description of key information

Key value for chemical safety assessment

Additional information

No key acute toxicity data is available for Resin acids and rosin acids, manganese salts (CAS# 9008-34-8) however, supportive data is available and is summarized below. In addition, key and supportive acute toxicity data is available for other members of the category 'Rosins and their salts'.

 

In a supportive (pre-Guideline, non-GLP) acute oral toxicity study (BASF 1972a RSS), Resin acids and rosin acids, manganese salts (CAS# 9008-34-8) present at 12% in a formulation was administered to young adult CFE rats (5/sex/dose) via oral gavage at doses of 5000 and 10000 mg/Kg bw (corresponding to 600 and 1200 mg/Kg of Resin acids and rosin acids, manganese salts) in a carboxymethyl cellulose vehicle. The remainder of the administered formulation was described as 'poorly soluble manganese complex'. No mortality was observed at the highest dose tested. Considering the absence of mortality or adverse effects at 1200 mg/kg bw, the LD50 of the formulation containing 12% Resin acids and rosin acids, manganese salts was determined to be ≥1200 mg/Kg bw. In view of the absence of any mortality at a dose of 1200 mg/Kg Resin acids and rosin acids, manganese salts, the LD50 is most likely >2000 mg/Kg.

 

The above acute toxicity data for Resin acids and rosin acids, manganese salts (CAS# 9008-34-8) is consistent with the acute toxicity information available for other members of the category Rosins and their salts, which shows that they are not classified for acute lethality by the oral or dermal routes of exposure under EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008. Please refer to the Category endpoint summary for further information on the acute toxicity of Rosins and their salts.

Results from investigations into the acute toxicity of the category Rosins and their salts are summarised briefly below:

Acute Oral Toxicity

In an early study that pre-dated the development of GLP and study guidelines, treatment of albino rats and guinea pigs with Wood Rosin (Rosin) at doses ranging from 1 -5 g/kg (rats) and 1 -4 g/kg (guinea pigs) resulted in an oral LD50 of 2.8 g/kg in rats and between 1 -2 g/kg in guinea pigs (Kodak Laboratory of Medicine, 1956).

In an acute oral toxicity study, a group of five male and five female rats was administered a single dose of Rosin, reaction products with formaldehyde (CAS No. 91081-53-7) by oral gavage at a dose level of 5000 mg/kg bw (Food & Drug Research Laboratories, Inc, 1985a). The rats were observed for mortality and adverse clinical signs for a period of 15 days. One of five males and two of five females were found dead on the morning following dosing (Day 2). A third female was found dead on Day 3. No other mortality was noted for male or female rats during the study. Abnormal clinical signs were reversible and included decreased activity (1/5 males and 1/5 females), diarrhea (2/5 males and 2/5 females), ataxia (1/5 females), and wet abdomen (2/5 females). No other abnormal clinical signs were evident during the study. All surviving animals of both sexes gained weight over the 15-day observation period. No gross pathological lesions were reported at necropsy. Based on the results of this study, the oral LD50 of Rosin, reaction products with formaldehyde (CAS No. 91081-53-7) is >5000 mg/kg bw in male and female rats.

In another acute oral toxicity study, a group of five male and five female rats was administered a single dose of Rosin, reaction products with formaldehyde (CAS No. 91081-53-7) by oral gavage at a dose level of 1000 mg/kg bw (Food & Drug Research Laboratories, Inc, 1985b). The rats were observed for mortality and adverse clinical signs for a period of 15 days. No mortality was noted during the study. Abnormal clinical signs were limited to diarrhea for a single male and a single female on the day of dosing and on the morning of the day after dosing. No other abnormal clinical signs were evident during the study. All animals of both sexes gained weight over the 15-day observation period. No gross pathological lesions were reported at necropsy. Based on the results of this study, the roal LD50 of Rosin, reaction products with formaldehyde (CAS No. 91081-53-7) is is >1000 mg/kg bw in male and female rats.

The acute oral toxicity of Rosin, oligomers was evaluated in an investigation that pre-dated the development of GLP and study guidelines but which was conducted according to acceptable scientific methodology in effect at the time (Wharf Institute, 1977a). In this study, a group of 10 rats/sex/group received a dose of 2500, 5000, 7500 or 10000 mg/kg bw of the test material administered by oral gavage. All animals in the 2500 mg/kg bw dose group survived to study termination while all females and 8 of 10 males in the high-dose group died. In the 5000 mg/kg bw dose group, 2 of 10 males and 3 of 10 females died.  In the 7500 mg/kg bw dose group, 1 of 10 males and 5 of 10 females died. There were no adverse clinical signs observed during the 14-day observation period and all animals surviving to study termination gained weight. Although a gross post mortem examination was performed on all animals, the results of those examinations were not provided in the study report. The oral LD50 for Rosin, oligomers was between 7500 and 10000 mg/kg bw for males, and between 5000 and 10000 mg/kg bw for females.

The acute oral toxicity of Resin acids and rosin acids, hydrogenated, potassium salts was evaluated in a study conducted according to OECD Guideline 420 (Eastman Kodak Company, 2005a). Following confirmation that a dose of 300 mg/kg bw administered by gavage to a single female rat was not toxic, five female rats were each administered a single dose of 2000 mg/kg bw of the test substance by gavage. All animals survived to study termination. All animals gained weight normally and there were no signs of systemic toxicity. The acute oral LD50 in this study was >2000 mg/kg bw for female rats. 

 

Resin acids and rosin acids, calcium zinc salts was administered to six female rats at a dose level of 2000 mg/kg bw after formulation in olive oil hours (Phycher Bio Developpement, 2010a). At all the observation points up to the termination of the study on day 14, no mortalities, clinical signs or macroscopic abnormalities were observed. The oral LD50 of the test item was greater than the limit dose of 2000 mg/kg bw.

Resin acids and rosin acids, magnesium salts was administered to six female rats at a dose level of 2000 mg/kg bw after formulation in olive oil hours (Phycher Bio Developpement, 2010b).One animal was found dead at 23h 50 min post-dosing. No clinical signs related to the administration of the test substance were observed, except for the single death described above. The oral LD50 of the test item was greater than the limit dose of 2000 mg/kg bw.

 

Acute Dermal Toxicity

In an acute dermal toxicity study, a group of five male and five female rats was administered a single dose of Gum Rosin (Rosin) topically, under a porous gauze dressing, at a dose level of 2000 mg/kg bw in dimethylsulfoxide vehicle for an exposure period of 24 hours (Phycher Bio Developpement, 2009a). Under the conditions of this study, the dermal LD50 of Gum Rosin in male and female Sprague-Dawley rats was > 2000 mg/kg bw. No mortality was observed in the study and, after an absence of body weight gain was noted in all males and females on Day 2, the animals recovered and gained weight normally over the rest of the study period. No systemic clinical signs related to the administration of the test substance were observed. Other than a slight dryness to dryness noted at the treatment site of one or more animals at various times during the study, there were no signs of irritation, necrosis, ulceration or evidence of tissue destruction reported. At necropsy, no gross lesions were observed. Based on the results of this study, Gum Rosin was not acutely toxic to rats via the dermal route.

The acute dermal toxicity of Resin acids and rosin acids, hydrogenated, potassium salts was evaluated in a study conducted according to OECD Guideline 402 (Eastman Kodak Company, 2004a). Five rats/sex were administered a single dose of 2000 mg/kg bw Resin acids and rosin acids, hydrogenated, potassium salts under occluded contact for 24 hours and observed for 14 days. All animals survived to study termination. All animals gained weight normally and there were no signs of skin absorption or systemic toxicity. The acute dermal LD50 in this study was >2000 mg/kg bw for male and female rats. 

Justification for classification or non-classification